Complete and Durable Response to Nivolumab in Recurrent Poorly Differentiated Pancreatic Neuroendocrine Carcinoma with High Tumor Mutational Burden.
Curr Oncol
; 28(6): 4587-4596, 2021 11 10.
Article
in En
| MEDLINE
| ID: mdl-34898561
Key words
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Carcinoma, Neuroendocrine
/
Small Cell Lung Carcinoma
/
Lung Neoplasms
Type of study:
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
Curr Oncol
Year:
2021
Document type:
Article
Affiliation country:
Taiwan
Country of publication:
Switzerland